SBIA
MRNA icon

Sheaff Brock Investment Advisors’s Moderna MRNA Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,468
Closed -$293K – 477
2024
Q2 		$293K Hold
2,468
– – 0.03% 329
2024
Q1 		$263K Hold
2,468
– – 0.02% 382
2023
Q4 		$245K Sell
2,468
-49
-2% -$4.12K 0.02% 379
2023
Q3 		$260K Hold
2,517
– – 0.02% 352
2023
Q2 		$306K Sell
2,517
-10
-0.4% -$1.33K 0.03% 343
2023
Q1 		$388K Sell
2,527
-197
-7% -$32.5K 0.04% 304
2022
Q4 		$489K Buy
2,724
+276
+11% +$45.1K 0.05% 255
2022
Q3 		$289K Sell
2,448
-79
-3% -$12K 0.03% 340
2022
Q2 		$361K Sell
2,527
-10
-0.4% -$1.43K 0.03% 298
2022
Q1 		$437K Sell
2,537
-2,270
-47% -$382K 0.03% 303
2021
Q4 		$1.22M Sell
4,807
-2,030
-30% -$594K 0.08% 162
2021
Q3 		$2.63M Buy
6,837
+128
+2% +$47.2K 0.19% 81
2021
Q2 		$1.58M Sell
6,709
-65
-1% -$11.6K 0.11% 116
2021
Q1 		$887K Buy
6,774
+390
+6% +$56.5K 0.07% 164
2020
Q4 		$667K Buy
6,384
+1,700
+36% +$172K 0.06% 196
2020
Q3 		$331K Buy
+4,684
New +$327K 0.03% 283

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sheaff Brock Investment Advisors's MRNA Position: Q3 2024 in Review

Sheaff Brock Investment Advisors sold out of Moderna (MRNA) in Q3 2024, closing a stake of 2,468 shares — an estimated $293K sold.

Sheaff Brock Investment Advisors first reported a position in MRNA in Q3 2020 and held it in 16 quarters. The position peaked at $2.63M in Q3 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Sheaff Brock Investment Advisors reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Sheaff Brock Investment Advisors sold 2,468 Moderna shares in Q3 2024, an estimated $293K.
  • Sheaff Brock Investment Advisors first reported a position in Moderna in Q3 2020 and held it in 16 quarters.
  • Sheaff Brock Investment Advisors's Moderna position peaked at $2.63M in Q3 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Sheaff Brock Investment Advisors's 13F filing for Q3 2024, filed 6 Nov 2024.